Blood-brain barrier (BBB) evidence

ATLXM0052572 · 0.006 mL/g/min

A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.

Resources

Manual Explanations Statistics Download

Developability

Profile Comparator

Atlas

About

Blood-brain barrier (BBB)

Measurement

ATLXM0052572

Peptide: ATLPC0002816
Endpoint: Blood-brain barrier (BBB)
ADMET domain: Distribution / Barrier
Value: 0.006 mL/g/min
Measurement type: Unidirectional influx (Kin / PS product) — Blood-to-brain unidirectional influx rate — Kin / permeability-surface-area product (mL·min⁻¹·g⁻¹), typically in situ brain perfusion.
Evidence layer: Comparable: structured measurement intended for within-endpoint comparison when assay context matches
Assay / model: Intravenous injection (multiple time regression) · blood-brain barrier
Condition: Kin · NA
Reference: Open

This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.

Download

About

Stack